Ultraviolet disinfecting apparatus

Details for Australian Patent Application No. 2002363320 (hide)

Owner Honeywell International Inc.

Inventors Saccomanno, Robert J

Agent Davies Collison Cave

Pub. Number AU-B-2002363320

PCT Number PCT/US02/34482

PCT Pub. Number WO2003/039604

Priority 10/284,709 30.10.02 US; 60/336,381 02.11.01 US; 10/268,567 09.10.02 US

Filing date 30 October 2002

Wipo publication date 19 May 2003

Acceptance publication date 16 February 2006

International Classifications

A61L 9/20 (2006.01) Disinfection, sterilisation or deodorisation of air

Event Publications

19 June 2003 Complete Application Filed

  Priority application(s): 10/284,709 30.10.02 US; 60/336,381 02.11.01 US; 10/268,567 09.10.02 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363320

16 February 2006 Application Accepted

  Published as AU-B-2002363320

15 June 2006 Standard Patent Sealed

31 August 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Feb 2006. Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000 2003

25 January 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Feb 2006 2003

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363321-Method and apparatus for purifying water

2002363319-Omega-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS